Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥78.26B | ¥79.00B | −0.9% |
| Operating Income | ¥1.03B | ¥6.66B | −84.5% |
| Ordinary Income | ¥2.36B | ¥5.16B | −54.3% |
| Net Income | ¥0.47B | ¥5.79B | −91.9% |
| ROE | 0.2% | 1.9% | - |
Executive Summary
For Q1 of the fiscal year ending December 2026, the most significant point is that, while Revenue was largely flat, Operating Income declined sharply due to the increased burden of selling, general and administrative expenses. Revenue was ¥78.26B (-0.9% YoY), Operating Income was ¥1.03B (-84.5%), Ordinary Income was ¥2.36B (-54.3%), and Net Income was ¥0.47B (-91.9%). Although the gross margin remained at 69.8%, SG&A expenses expanded to account for 98.1% of gross profit, substantially squeezing operating profitability.
Factors Affecting Earnings
【Revenue】Revenue was ¥78.26B, essentially flat at -0.9% YoY. The Cosmetics Business, with Revenue of ¥63.92B (+0.6%), is the core business and accounted for 81.7% of total Revenue, but growth was limited. The Cosmetary Business recorded a decline in Revenue to ¥13.65B (-7.8%). By region, Japan, at ¥48.16B (-7.0%), weighed on overall performance, while overseas markets grew, with Asia at ¥11.37B (+16.4%) and North America at ¥16.67B (+8.4%), partially offsetting the domestic weakness.
【Profit and Loss】Operating Income was ¥1.03B (-84.5%), and the Operating Income margin fell sharply to 1.3% from 8.4% in the same period of the previous year. The Cosmetics Business margin declined from 9.4% to 3.7%, while the Cosmetary Business turned to an operating loss of ¥0.12B. Ordinary Income of ¥2.36B exceeded Operating Income, attributable to ¥1.38B in non-operating income, including a ¥0.74B foreign exchange gain; thus, non-operating factors supplemented the weakness in the core business. Net Income of ¥0.47B declined by more than Ordinary Income due to an effective tax rate of approximately 79% against Profit Before Tax of ¥2.24B. In extraordinary gains and losses, an extraordinary loss of ¥0.27B, including impairment losses and other items, was recorded against a gain on the sale of investment securities of ¥0.15B, representing a temporary factor that reduced Profit Before Tax by ¥0.12B. In conclusion, although there are signs of Revenue growth, the Company posted a substantial decline in profit amid essentially flat Revenue close to a decline, resulting in a structure effectively resembling lower Revenue and lower profit.
Segment Analysis
The Cosmetics Business recorded Revenue of ¥63.92B (+0.6%), Operating Income of ¥2.33B (-61.1%), and a margin of 3.7% (9.4% in the previous year). Although it remains the center of consolidated earnings, profitability deteriorated substantially. The Cosmetary Business recorded Revenue of ¥13.65B (-7.8%) and an operating loss of ¥0.12B, reversing from approximately ¥1.85B of profit in the previous year, as the Revenue decline coincided with reduced cost absorption capacity. Other Businesses, including amenity products, recorded Revenue of ¥0.96B (+19.1%) and profit of ¥0.51B (+41.7%), maintaining a high margin of 53.3% despite their small scale. By region, Japan is the largest market, accounting for 61.5%, but Revenue declined 7.0%; growth in Asia and North America is supporting the Company as a whole.
Key Financial Indicators
【Profitability】The Operating Income margin declined sharply to 1.3% from 8.4% in the same period of the previous year, while the Net Income margin also contracted substantially from the previous year to approximately 0.5%. The gross margin remained high at 69.8%, indicating that the burden of SG&A expenses, rather than the cost structure, was the primary cause of the deterioration in profitability.【Cash Quality】Cash and deposits were ¥73.48B, accounting for 19.0% of total assets. Ordinary Income has a high degree of dependence on factors outside the core business, as non-operating income included a ¥0.74B foreign exchange gain.【Investment Efficiency】ROE remained at 0.2% (high on a same-period annualized basis in the previous year). Corporate income taxes and other taxes of ¥1.77B against Profit Before Tax of ¥2.24B represented a heavy tax burden, reducing profit conversion efficiency.【Financial Soundness】The Equity Ratio remained high at 77.4% (equivalent to 77.5% in the previous year), while current assets of ¥207.42B against current liabilities of ¥61.99B indicate sound short-term payment capacity.
Cash Flow Analysis
Although the cash flow statement has not been disclosed, the movement of funds can be inferred from changes in the balance sheet. Cash and deposits were ¥73.48B, down from ¥92.46B in the same period of the previous year. Inventories were ¥44.22B, slightly up from ¥43.54B in the same period of the previous year, suggesting a tendency for funds to remain tied up in inventory. Property, plant and equipment was ¥96.51B, up from ¥81.80B in the same period of the previous year, with capital expenditures including ¥37.64B in construction in progress representing the primary use of funds. The substantial decline in Net Income, combined with increased capital expenditures, is considered to have led to a decrease in cash on hand.
Earnings Quality
Ordinary Income of ¥2.36B exceeded Operating Income of ¥1.03B, but most of the difference was attributable to ¥1.38B in non-operating income, centered on a ¥0.74B foreign exchange gain. This represents a structure in which non-operating factors supplement the earning power of the core business. In extraordinary gains and losses, an extraordinary gain of ¥0.15B, including a ¥0.15B gain on the sale of investment securities, was recorded against extraordinary losses of ¥0.27B, including an impairment loss of ¥0.04B; both were non-recurring items that reduced Profit Before Tax. Corporate income taxes and other taxes of ¥1.77B were recorded against Profit Before Tax of ¥2.24B, resulting in a high effective tax rate of approximately 79% and amplifying the decline in Net Income. Comprehensive Income was ¥0.50B, close to Net Income of ¥0.47B; however, a foreign currency translation adjustment of +¥0.42B and an adjustment related to retirement benefits of -¥0.53B offset each other. Together with the valuation difference on available-for-sale securities, factors unrelated to recurring earning power affected Comprehensive Income.
Earnings Forecast and Guidance
The full-year forecast is Revenue of ¥350.00B (+6.0% YoY), Operating Income of ¥20.00B (+8.3%), and Ordinary Income of ¥21.00B (-2.2%), with no in-period revision to either the earnings forecast or dividend forecast. Q1 progress rates were 22.4% for Revenue, 5.2% for Operating Income, 11.2% for Ordinary Income, and 3.5% for Net Income attributable to owners of the parent. All were below the simple 25% progress benchmark, with the delay particularly pronounced in profit. Achieving the full-year plan will require a substantial recovery in the pace of earnings growth from Q2 onward through improved SG&A efficiency and a recovery in the profitability of the Cosmetary Business.
Shareholder Returns
The full-year dividend forecast is ¥150 per share, consisting of an ordinary dividend of ¥70 and a year-end dividend of ¥80, including a commemorative dividend of ¥10. Based on the full-year forecast EPS of ¥212.67, the Payout Ratio is approximately 70.5%. Because the dividend includes a commemorative dividend, it needs to be evaluated separately from the sustainable Payout Ratio based on the ordinary dividend. Cash and deposits were ¥73.48B, while interest-bearing debt was limited to ¥0.84B in short-term borrowings; therefore, the financial foundation is not considered to impose significant constraints on securing funds for dividends. However, Net Income attributable to owners of the parent in Q1 represented only 3.5% of the full-year forecast, meaning the realization of the funds available for dividends depends on a recovery in profit from Q2 onward.
Risk Factors
-
Decline in domestic demand: Revenue in Japan was ¥48.16B, down -7.0% YoY. A delayed recovery in the domestic market, which accounts for 61.5% of total Revenue, will affect both growth and profit margins.
-
Deterioration in the profitability of the core business: Operating Income in the Cosmetics Business was ¥2.33B (-61.1%), and its margin declined from 9.4% to 3.7%. Restoring the earning power of this core contributor to consolidated profit remains a key challenge.
-
High effective tax rate: Corporate income taxes and other taxes of ¥1.77B were recorded against Profit Before Tax of ¥2.24B, resulting in an effective tax rate of approximately 79%. Even when profit is secured before tax, its conversion into Net Income is significantly constrained.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 1.3% | 7.2% (3.2%–12.5%) | −5.9pt |
| Net Income Margin | 0.6% | 5.9% (2.9%–12.5%) | −5.3pt |
The Company's profitability is substantially below the industry median.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −0.9% | 5.6% (1.1%–13.9%) | −6.5pt |
Revenue growth is also below the industry median, indicating a gap relative to peer companies experiencing Revenue growth.
※Source: Compiled by the Company
Key Points from the Earnings Results
-
Despite maintaining a high-value-added earnings foundation with a gross margin of 69.8%, the fact that SG&A expenses accounted for 98.1% of gross profit and reduced the Operating Income margin to 1.3% warrants attention as an area for monitoring the cost structure.
-
While overseas markets (Asia and North America) continue to grow Revenue, Japan recorded a 7.0% decline, and changes in regional demand structures are reflected in the Revenue composition.
-
The progress rate for full-year plan profit was only 5.2% for Operating Income, making a substantial improvement in profitability from Q2 onward a prerequisite for achieving the plan. This will be a key point to monitor in future earnings results.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥4,252 |
| base | ¥4,304 |
| bull | ¥4,347 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥4,913 |
| Adjusted Forecast EPS | ¥228.6 |
| Cost of Equity r | 9.27% (10-year JGB 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 70.5% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the historical guidance achievement rate of companies in the same industry) |
| Implied PBR / PER | 0.88x / 18.8x |
Sensitivity: ¥4,189–¥4,425 at ±1% for the cost of equity, and ¥4,285–¥4,317 at ±0.1 for ω.
Notes:
- Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).
(Calculation model: Residual Income Model (Ohlson type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q1 was a materially weak earnings start, as broadly flat revenue was accompanied by a severe contraction in operating and net profit. Revenue declined 0.9% year on year to ¥78.27bn. Gross profit declined 3.5% to ¥54.61bn, exceeding the rate of revenue decline. The gross margin contracted by 190bp year on year to 69.8%. SG&A expenses increased 7.3% to ¥53.58bn despite the revenue decline. As a result, the SG&A-to-revenue ratio rose by approximately 520bp to 68.5%. Operating income fell 84.5% to ¥1.03bn. The operating margin consequently compressed by approximately 710bp to 1.3%, well below the level generally associated with a healthy cosmetics franchise. Ordinary income declined 54.3% to ¥2.36bn, with non-operating income, particularly ¥0.74bn of FX gains and ¥0.26bn of interest income, supporting profit below the operating line. Profit attributable to owners of parent fell 91.9% to ¥0.43bn, producing EPS of ¥7.48. The net margin declined by approximately 620bp to 0.5%. A ¥1.47bn gain on sales of investment securities, partly offset by ¥0.38bn of impairment loss and ¥0.23bn of fixed-asset disposal loss, also affected the comparability of bottom-line earnings. The effective tax rate was exceptionally high at 79.1%, leaving a tax burden of only 0.190 and sharply reducing conversion of pre-tax profit into net income. Segment performance indicates that the core Cosmetics business remained profitable but suffered a substantial earnings contraction, while the Cosmetary business moved into a loss. Regionally, domestic sales declined materially, whereas Asia and North America expanded, increasing the importance of overseas execution and foreign-exchange effects. The balance sheet remains a major source of resilience, with a 334.6% current ratio, net cash characteristics and debt representing only 0.3% of capital. However, elevated inventory days, a long cash-conversion cycle, and a large construction-in-progress balance require close monitoring. Q1 progress toward the full-year operating-income forecast is only 5.2%, materially below the 25% seasonal reference point, implying that a pronounced profit recovery is embedded in the remaining quarters. The full-year plan was not revised, so subsequent evidence of gross-margin restoration, advertising productivity, inventory normalization and overseas profit conversion will be central to assessing delivery risk.
Profitability Analysis
The reported annualized DuPont ROE is 0.6%, decomposed into a 0.5% net profit margin, 0.808x asset turnover and 1.29x financial leverage. The primary constraint is profitability rather than asset utilization or leverage: the company maintains modest leverage, but very little of Q1 revenue converted into owner earnings. The net margin declined from approximately 6.7% in the prior-year quarter to 0.5%, a deterioration of roughly 616bp. At the operating level, gross margin fell from approximately 71.7% to 69.8%, while the SG&A ratio rose from approximately 63.2% to 68.5%. This combined 711bp operating-margin decline, from approximately 8.4% to 1.3%, was the largest driver of the ROE deterioration. The cost base showed negative operating leverage because SG&A rose 7.3% while sales fell 0.9%. Advertising expenses increased 28.8% year on year to ¥7.67bn, and salaries and allowances increased 4.3% to ¥14.11bn; these investments were not absorbed by sales growth in Q1. The core Cosmetics segment generated ¥63.92bn of revenue, up 0.6%, but segment profit fell 61.1% to ¥2.33bn, reducing its segment margin from 9.4% to 3.7%. Cosmetary revenue declined 7.8% to ¥13.65bn and segment profit shifted from ¥1.85bn to a ¥0.12bn loss. Other businesses delivered ¥6.93bn of revenue, up 2.1%, and segment profit increased 41.7% to ¥0.51bn, although this remains smaller than the two reportable businesses. Unallocated corporate costs and basic research expenses decreased to ¥1.44bn from ¥1.56bn, but this reduction was insufficient to offset the decline in segment profitability. Financial leverage of 1.29x is conservative and is not inflating return metrics. Interest coverage of 79.23x confirms that financing cost is not a constraint. The unusually high tax rate caused a further drop from pre-tax income of ¥2.24bn to owner-attributable income of ¥0.43bn. Profitability recovery therefore depends principally on restoring gross margin and extracting revenue productivity from selling, promotional and personnel spending rather than on balance-sheet actions.
Growth Assessment
Revenue performance was subdued in Q1, with consolidated sales down 0.9% year on year to ¥78.27bn. The geographic mix was polarized: Japan sales fell 7.0% to ¥48.16bn, while Asia increased 16.4% to ¥11.37bn and North America increased 8.4% to ¥16.67bn. Japan remained the largest geography at 61.5% of revenue, so its decline outweighed overseas growth. North America accounted for 21.3% of Q1 sales and Asia for 14.5%, indicating an increasingly meaningful overseas earnings base. The Cosmetics segment, the core business by operating-income contribution, posted modest sales growth but significantly lower profit, indicating that its current issue is monetization rather than top-line demand alone. The Cosmetary segment’s sales decline and shift to loss represent the most acute segment-level earnings pressure. Full-year guidance calls for revenue of ¥350.0bn, up 6.0% year on year, operating income of ¥20.0bn, up 8.3%, ordinary income of ¥21.0bn and owner-attributable profit of ¥12.1bn. Q1 revenue represents 22.4% of the full-year sales plan, only 2.6 percentage points below the standard 25% Q1 reference. In contrast, Q1 operating income represents only 5.2% of the full-year forecast, 19.8 percentage points below the standard reference. Ordinary-income progress is 11.2%, 13.8 percentage points below the reference, while owner-attributable-profit progress is 3.5%, 21.5 percentage points below it. The guidance therefore requires not only sales acceleration but also a substantial margin recovery after Q1. The absence of a forecast revision preserves management's recovery assumptions but does not reduce execution risk. Sales growth appears more sustainable in Asia and North America than in Japan based on the quarter's regional trends, although the profit contribution from that growth must improve. The increase in advertising spending may support future brand demand, but its near-term return on investment has not yet been demonstrated by Q1 operating results.
Financial Health
Financial health remains strong despite the weak Q1 income statement. Current assets were ¥207.42bn against current liabilities of ¥61.99bn, resulting in a current ratio of 334.6% and working capital of ¥145.43bn. The quick ratio was also robust at 263.3%, demonstrating that liquidity is not dependent on inventory realization. Cash and deposits totaled ¥73.48bn, equal to 87.37x short-term loans of ¥0.84bn. Interest-bearing debt was limited to ¥0.84bn, while debt-to-equity was 0.29x and debt-to-capital was 0.3%. Total liabilities were only 22.6% of total assets, with total equity of ¥299.85bn supporting a capital adequacy ratio of 72.1%. All reported debt is short term, giving a 100% short-term debt ratio and triggering the refinancing-risk alert. The root cause is the maturity profile rather than debt magnitude: short-term borrowings are concentrated within one year. In context, the refinancing risk is low at present because cash exceeds short-term loans by a very large margin and current assets comfortably cover current liabilities. The practical impact is limited liquidity risk but a need to monitor whether short-term borrowing expands to fund investment or working capital. Lease obligations total ¥9.93bn, comprising ¥1.68bn current and ¥8.25bn non-current, and should be considered alongside reported borrowings when evaluating fixed commitments. Goodwill of ¥5.21bn equals only 1.7% of equity and 1.3% of assets, while intangible assets represent 6.3% of assets; balance-sheet dependence on acquisition values is therefore low. Deferred tax liabilities of ¥12.20bn exceed deferred tax assets of ¥6.76bn, consistent with a balance sheet that contains accumulated valuation and translation reserves. The balance-sheet structure provides capacity to withstand a temporary earnings downturn, but prolonged sub-5% operating margins would progressively weaken capital efficiency.
Notable B/S Changes
Cash and deposits: -¥189.87bn (-20.5%) year on year to ¥734.75bn — liquidity remains ample, but the decline should be assessed against investment spending, working-capital use and shareholder distributions. Property, plant and equipment: +¥147.13bn (+18.0%) year on year to ¥965.13bn — a substantial increase in the fixed-asset base raises the importance of utilization and return-on-capital delivery. Construction in progress: +¥153.80bn (+69.1%) year on year to ¥376.42bn — projects represent 39.0% of PPE, indicating elevated project-completion and investment-return risk. Accounts receivable: -¥67.23bn (-12.0%) year on year to ¥493.52bn — supportive of collections and working-capital discipline. Work in process: +¥8.76bn (+22.3%) year on year to ¥48.07bn — higher production-stage inventory warrants monitoring alongside inventory-day alerts and demand trends. Treasury stock: -¥16.21bn (increase in carrying amount of 17.9%) to -¥106.52bn — indicates increased treasury-share holdings and reduces reported equity available per issued share. Capital surplus: +¥4.74bn (+230.1%) year on year to ¥6.80bn — a notable equity-composition movement. Goodwill: -¥4.17bn (-7.4%) year on year to ¥52.12bn — low absolute exposure limits goodwill impairment risk.
Cash Flow Quality
Operating cash flow, investing cash flow, financing cash flow and capital-expenditure totals are not provided, so cash conversion and free-cash-flow coverage cannot be quantified. Q1 earnings quality is nevertheless weakened by the large divergence between operating and ordinary income: operating income was ¥1.03bn, while ordinary income was ¥2.36bn. The difference was supported primarily by ¥0.74bn of foreign-exchange gains, ¥0.26bn of interest income and ¥0.07bn of dividend income. FX gains alone equaled 71.9% of operating profit, triggering the FX-exposure alert. The root cause is that a relatively small operating-profit base magnifies the impact of currency movements. For an international cosmetics group, some FX sensitivity is structurally expected because overseas sales are meaningful, but the current magnitude makes reported ordinary profit materially less representative of underlying operating performance. The impact is heightened volatility in reported earnings and a need to distinguish local-currency business improvement from translation or transactional FX gains. Extraordinary items were modest in absolute terms but relevant to the small net-profit base: ¥1.49bn of extraordinary income included a ¥1.47bn gain on sales of investment securities, while extraordinary losses totaled ¥2.69bn, including ¥0.38bn of impairment and ¥0.23bn of fixed-asset disposal losses. The high 79.1% effective tax rate was the largest direct impediment to conversion of pre-tax income into owner earnings. Inventory efficiency alerts indicate inventory days of 291 days and 171 days under the provided calculations; both readings exceed their respective 90-day and 60-day warning thresholds. The root cause is the large inventory balance relative to Q1 cost of sales, with inventories of ¥44.22bn. The long cash-conversion-cycle alert of 308 days similarly indicates substantial capital tied up in inventory and the operating cycle. This is particularly important for cosmetics because slow-moving finished goods can face markdown, obsolescence or write-down risk as product and packaging cycles evolve. Finished goods were ¥44.22bn, raw materials were ¥26.38bn and work in process was ¥4.81bn; these balances require monitoring alongside sales momentum. Receivables declined 12.0% year on year to ¥49.35bn, while trade payables increased 14.6% to ¥10.55bn and electronically recorded obligations declined 28.9% to ¥9.34bn. The reduction in receivables is supportive of working-capital discipline, but it does not offset the inventory intensity indicated by the alerts. Construction in progress totaled ¥37.64bn, or 39.0% of PPE, triggering the high-CIP alert. The root cause is a substantial investment pipeline, and the impact is execution risk: delayed commissioning or weak returns from projects could defer cash generation and depress returns on capital.
Dividend Sustainability
The full-year forecast specifies DPS of ¥150 and EPS of ¥212.67, implying a forecast dividend payout ratio of approximately 70.5%. This is above the stated 60% sustainability benchmark, though it remains below 100%. The dividend note identifies an expected year-end dividend of ¥80 per share, comprising a ¥70 ordinary dividend and a ¥10 commemorative dividend; together with the provided full-year DPS forecast, this indicates that the annual distribution includes an interim component. The ordinary year-end component represents a more recurring distribution than the commemorative portion. Q1 EPS was only ¥7.48, so annualizing the quarter mechanically would not support the forecast distribution; however, the company’s full-year earnings forecast implies a substantial recovery in later quarters. Cash and deposits of ¥73.48bn, negligible short-term loans and equity of ¥299.85bn provide a balance-sheet buffer for shareholder returns. Retained earnings of ¥246.90bn also provide substantial accounting capacity. Sustainability ultimately depends on management delivering the forecast recovery because Q1 owner earnings covered only a small fraction of the anticipated annual dividend. Free-cash-flow coverage cannot be assessed from the provided period data. The key considerations are whether operating margin recovers, inventory is converted into cash, and construction projects avoid absorbing an excessive share of internally generated funds. The commemorative ¥10 year-end component should not be treated as a recurring baseline dividend when evaluating normalized payout capacity.
Risk Assessment
Business risks include High priority — Margin-recovery risk: operating margin fell to 1.3% from approximately 8.4% as gross margin contracted and SG&A increased faster than revenue. The full-year plan requires a sharp reversal., High priority — Japan demand and channel risk: Japan revenue declined 7.0% and remains 61.5% of consolidated Q1 sales, leaving group growth sensitive to recovery in its largest market., High priority — Inventory and product-cycle risk: inventory-day alerts of 291 days and 171 days, together with a 308-day cash-conversion cycle, indicate elevated inventory carrying, markdown and obsolescence exposure for a cosmetics manufacturer., Medium-high priority — Cosmetary turnaround risk: segment revenue declined 7.8% and profit moved from ¥1.85bn to a ¥0.12bn loss., Medium priority — Overseas execution risk: Asia and North America grew, but translating revenue growth into segment profit is essential as international markets increase in importance., Medium priority — Advertising-return risk: advertising expense increased 28.8% to ¥7.67bn while group sales declined, creating risk that marketing investment does not generate sufficient incremental sales or margin..
Financial risks include High priority — Capital-efficiency risk: the annualized reported ROE was 0.6% and the ROIC alert is 0.9%, both far below normal return thresholds. The root cause is weak operating profit on a substantial asset and equity base; the impact is reduced value creation unless margins recover., Medium priority — FX exposure: FX gains of ¥0.74bn equaled 71.9% of operating profit. This level of dependence makes ordinary earnings vulnerable to currency reversals., Medium priority — Investment-execution risk: construction in progress was ¥37.64bn, 39.0% of PPE. The high-CIP alert reflects a large unfinished investment base whose timing and returns need validation., Low priority — Refinancing profile risk: 100% of reported debt is short term, but the absolute amount is only ¥0.84bn and cash coverage is 87.37x. The maturity concentration should be monitored, although current liquidity materially mitigates the risk., Low priority — Tax-rate volatility: the 79.1% effective tax rate substantially reduced profit conversion in Q1 and could continue to distort quarterly net earnings..
Key concerns include Q1 operating-income progress of 5.2% versus the full-year forecast is 19.8 percentage points below the standard Q1 progress reference., SG&A growth exceeded revenue growth by approximately 8.2 percentage points, creating negative operating leverage., Operating earnings were supplemented by non-operating FX and interest income, reducing the representativeness of ordinary income., Both reported inventory-day alerts exceed warning thresholds, and the long cash conversion cycle points to working-capital intensity., No material segment goodwill or fixed-asset impairment was reported in Q1, and goodwill exposure remains low; this limits current M&A-related balance-sheet risk..
Investment Implications
Key takeaways include The Q1 earnings shortfall is principally an operating-margin issue, not a leverage or liquidity issue., The Cosmetics business remains the core profit contributor, but its segment margin fell sharply despite modest revenue growth., Asia and North America delivered growth that partly offsets a pronounced Japan decline, but their profitability and FX sensitivity remain important., The company has substantial liquidity and very low reported borrowing, providing resilience during a recovery period., High inventory intensity, a 308-day cash-conversion-cycle alert and a large construction-in-progress balance are the principal balance-sheet efficiency issues., Full-year guidance implies a heavily back-end-loaded earnings recovery, with operating-income delivery the critical test..
Metrics to watch include Consolidated gross margin and operating margin, Advertising and promotion expense growth relative to revenue growth, Cosmetics and Cosmetary segment profit margins, Japan, Asia and North America revenue growth and local profitability, Inventory days, inventory balance and any inventory valuation charges, Cash conversion cycle and receivables/payables movements, Construction-in-progress commissioning, project completion and return profile, FX gains or losses relative to operating income, Effective tax rate and conversion of pre-tax income into owner earnings, Progress against the ¥20.0bn full-year operating-income forecast.
Regarding relative positioning, The company is financially conservative, with stronger liquidity and lower balance-sheet leverage than a highly indebted consumer-products operator, but its Q1 profitability and capital efficiency are currently weak. Its 69.8% gross margin remains characteristic of a branded cosmetics model, yet the 1.3% operating margin indicates that selling, promotion and fixed-cost absorption are presently eroding the economic benefit of that gross-profit base.